Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Meeting Report
  • Published:

Assessing the potential role of photopheresis in hematopoietic stem cell transplant

Abstract

The First International Symposium on Photopheresis in Hematopoietic Stem Cell Transplantation was held in Vienna, Austria with an educational grant from Therakos Inc. from 25 May to 27 May 2005. Three general issues were addressed: (1) pathophysiology of graft-versus-host disease (GvHD), (2) induction of immune tolerance and the immunology of phototherapy and (3) current standard treatment and prevention strategies of acute and chronic GvHD and the use of extracorporeal photopheresis (ECP). The objectives of the meeting were to open a dialogue among leading researchers in photobiology, immunology, and hematopoietic stem cell transplantation; foster discussions and suggestions for future studies of the mechanism of action of ECP in acute and chronic GvHD; and promote collaboration between basic scientists and clinicians. As can be seen from the summaries of the individual presentations, important advances have been made in our understanding of GvHD, including the use of photoimmunology interventions and the development of robust model systems. It is our expectation that data from photoimmunology studies can be used to generate hypotheses in animal models that can further define the mechanism of action of ECP and help translate the findings to clinical trials of ECP for the prophylaxis and treatment of both chronic and acute GvHD.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Ferrara JLM, Cooke KR, Teshima T . The pathophysiology of acute graft-versus-host disease. Int J Hematol 2003; 78: 181–187.

    Article  CAS  PubMed  Google Scholar 

  2. Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, Liu J et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999; 285: 412–415.

    Article  CAS  PubMed  Google Scholar 

  3. Teshima D, Ordemann R, Reddy P, Gagin S, Liu C, Cooke KR et al. Acute graft vs host disease does not require alloantigen expression on host epithelium. Nat Med 2002; 8: 575–581.

    Article  CAS  PubMed  Google Scholar 

  4. Ordemann R, Hutchinson R, Friedman J, Burakoff SJ, Reddy P, Duffner U et al. Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease. J Clin Invest 2002; 109: 1249–1256.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Lin MT, Storer B, Martin PJ, Tseng LH, Gooley T, Chen PJ et al. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med 2003; 349: 2201–2210.

    Article  CAS  PubMed  Google Scholar 

  6. Murai M, Yoneyama H, Ezaki T, Suematsu M, Terashima Y, Harada A et al. Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction. Nat Immunol 2003; 4: 154–160.

    Article  CAS  PubMed  Google Scholar 

  7. Matte C, Liu J, Cormier J, Anderson BE, Athanasiadis I, Jain D et al. Donor APCs are required for maximal GVHD but not for GVL. Nat Med 2004; 10: 987–992.

    Article  CAS  PubMed  Google Scholar 

  8. Steinman RM, Turley S, Mellman I, Inaba K . The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 2000; 191: 411–416.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Albert ML . Death-defying immunity: do apoptotic cells influence antigen processing and presentation? Nat Rev Immunol 2004; 4: 223–231.

    Article  CAS  PubMed  Google Scholar 

  10. Savill J, Dransfield I, Gregory C, Haslett C . A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2002; 2: 965–975.

    Article  CAS  PubMed  Google Scholar 

  11. Kripke ML . Antigenicity of murine skin tumors induced by ultraviolet light. J Natl Cancer Inst 1974; 53: 1333–1336.

    Article  CAS  PubMed  Google Scholar 

  12. Yoshikawa T, Rae V, Bruins-Slot W, Van-den Berg JW, Taylor JR, Streilein JM et al. Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans. J Invest Dermatol 1990; 95: 530–536.

    Article  CAS  PubMed  Google Scholar 

  13. Ullrich SE . Mechanisms underlying UV-induced immune suppression. Mutat Res 2005; 571: 185–205.

    Article  CAS  PubMed  Google Scholar 

  14. Vink AA, Moodycliffe AM, Shreedhar V, Ullrich SE, Roza L, Yarosh DB et al. The inhibition of antigen-presenting activity of dendritic cells resulting from UV irradiation of murine skin is restored by in vitro photorepair of cyclobutane pyrimidine dimmers. Proc Natl Acad Sci USA 1997; 94: 5255–5260.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Nishigori C, Yarosh DB, Ullrich SE, Vink AA, Bucana CD, Roza L et al. Evidence that DNA damage triggers interleukin 10 cytokine production in UV-irradiated murine keratinocytes. Proc Natl Acad Sci USA 1996; 93: 10354–10359.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Moyal D . Immunosuppression induced by chronic ultraviolet irradiation in humans and its prevention by sunscreens. Eur J Dermatol 1998; 8: 209–211.

    CAS  PubMed  Google Scholar 

  17. Nghiem DX, Kazimi N, Clydesdale G, Ananthaswamy HN, Kripke ML, Ullrich SE . Ultraviolet a radiation suppresses an established immune response: implications for sunscreen design. J Invest Dermatol 2001; 117: 1193–1199.

    Article  CAS  PubMed  Google Scholar 

  18. Maeda A, Schwarz A, Kernebeck K, Gross N, Aragane Y, Peritt D et al. Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. J Immunol 2005; 174: 5968–5976.

    Article  CAS  PubMed  Google Scholar 

  19. Schwarz A, Maeda A, Kernebeck K, van Steeg H, Beissert S, Schwarz T . Prevention of UV radiation-induced immunosuppression by IL-12 is dependent on DNA repair. J Exp Med 2005; 201: 173–179.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Hoetzenecker W, Meingassner JG, Ecker R, Stingl G, Stuetz A, Elbe-Burger A et al. Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells. J Invest Dermatol 2004; 122: 673–684.

    Article  CAS  PubMed  Google Scholar 

  21. Zic JA, Miller JL, Stricklin GP, King LE . The North American experience with photopheresis. J Ther Apher 1999; 4: 347–348.

    Google Scholar 

  22. Peritt D . Potential mechanisms of photopheresis in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006; 12: 7–12.

    Article  CAS  PubMed  Google Scholar 

  23. Bacigalupo A, Palandri F . Management of acute graft versus host disease. Hematol J 2004; 5: 189–196.

    Article  CAS  PubMed  Google Scholar 

  24. Edinger M, Hoffmann P, Ermann J, Drago K, Fathman CG, Strober S et al. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 2003; 9: 1144–1150.

    Article  CAS  PubMed  Google Scholar 

  25. Hoffmann P, Ermann J, Edinger M . Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 2002; 196: 389–399.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Ermann J, Hoffmann P, Edinger M, Dutt S, Blankenberg FG, Higgins JP et al. Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GvHD. Blood 2005; 105: 2220–2226.

    Article  CAS  PubMed  Google Scholar 

  27. Khoury H, Trinkaus K, Zhang MJ, Adkins D, Brown R, Vij R et al. Hydroxychloroquine for the prevention of acute graft-versus-host disease after unrelated donor transplantation. Biol Blood Marrow Transplant 2003; 9: 714–721.

    Article  CAS  PubMed  Google Scholar 

  28. Mielcarek M, Martin PJ, Leisenring W, Flowers ME, Maloney DG, Sandmaier BM et al. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood 2003; 102: 756–762.

    Article  CAS  PubMed  Google Scholar 

  29. Beelen DW, Elmaagacli A, Muller KD, Hirche H, Schaefer UW . Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and long-term follow-up of an open-label prospective randomized trial. Blood 1999; 93: 3267–3275.

    CAS  PubMed  Google Scholar 

  30. Martin PJ, Schoch G, Fisher L, Byers V, Appelbaum FR, McDonald GB et al. A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. Blood 1990; 76: 1464–1472.

    CAS  PubMed  Google Scholar 

  31. Van Lint MT, Uderzo C, Locasciulli A, Majolino I, Scime R, Locatelli R et al. Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation. Blood 1998; 92: 2288–2293.

    CAS  PubMed  Google Scholar 

  32. Sormani MP, Oneto R, Bruno B, Fiorone M, Lamparelli T, Gualandi F et al. A revised day +7 predictive score for transplant-related mortality: serum cholinesterase, total protein, blood urea nitrogen, gamma glutamyl transferase, donor type and cell dose. Bone Marrow Transplant 2003; 32: 205–211.

    Article  CAS  PubMed  Google Scholar 

  33. Bacigalupo A, Oneto R, Lamparelli T, Gualandi F, Bregante S, Raiola AM et al. Pre-emptive therapy of acute graft versus host disease: a pilot study with anti-thymocyte globulin (ATG). Bone Marrow Transplant 2001; 28: 1093–1096.

    Article  CAS  PubMed  Google Scholar 

  34. Greinix HT, Volc-Platzer B, Kalhs P, Fischer G, Rosenmayr A, Keil F et al. Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study. Blood 2000; 96: 2426–2431.

    CAS  PubMed  Google Scholar 

  35. Greinix HT, Volc-Platzer B, Rabitsch W, Gmeinhart B, Guevara-Pineda C, Kalhs P et al. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood 1998; 92: 3098–3104.

    CAS  PubMed  Google Scholar 

  36. Greinix HT, Knobler RM, Worel N, Schneider B, Schneeberger A, Hoecker P et al. Intensified extracorporeal photochemotherapy in severe acute graft-versus-host disease results in long-term improved survival. Hematol J 2006; 91: 405–408.

    Google Scholar 

  37. Salvaneschi L, Perotti C, Zecca M, Bernuzzi S, Viarengo G, Georgiani G et al. Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood. Transfusion 2001; 41: 1299–1305.

    Article  CAS  PubMed  Google Scholar 

  38. Messina C, Locatelli F, Lanino E, Uderzo C, Zacchello G, Cesaro S et al. Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation. Br J Haematol 2003; 122: 118–127.

    Article  CAS  PubMed  Google Scholar 

  39. Smith EP, Sniecinski I, Dagis AC, Parker PM, Snyder DS, Stein AS et al. Extracorporeal photochemotherapy for treatment of drug-resistant graft-vs. host disease. Biol Blood Marrow Transplant 1998; 4: 27–37.

    Article  CAS  PubMed  Google Scholar 

  40. Worel N, Biener D, Kalhs P, Mitterbauer M, Keil F, Schulenburg A et al. Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation. Bone Marrow Transplant 2002; 30: 619–626.

    Article  CAS  PubMed  Google Scholar 

  41. Socié G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 1999; 341: 14–21.

    Article  PubMed  Google Scholar 

  42. Wingard JR, Piantadosi S, Vogelsang GB, Farmer ER, Jabs DA, Levin LS et al. Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. Blood 1989; 74: 1428–1435.

    CAS  PubMed  Google Scholar 

  43. Hakim FT, Mackall CL . The immune system: effector and target of graft-versus-host disease. In: Ferrara JLM, Deeg HJ, Burakoff SJ (eds). Graft-vs.-Host Disease, 2nd edn. Marcel Dekker, Inc: New York, NY, 1997, pp. 257–289.

    Google Scholar 

  44. Sullivan KM, Witherspoon RP, Storb R, Deeg HJ, Dahlberg S, Sanders JE et al. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. Blood 1988; 72: 555–561.

    CAS  PubMed  Google Scholar 

  45. Koc S, Leisenring W, Flowers ME, Anasetti C, Deeg HJ, Nash RA et al. Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone. Blood 2002; 100: 48–51.

    Article  CAS  PubMed  Google Scholar 

  46. Lopez F, Parker P, Nademanee A, Rodriguez R, Al-Kadhimi Z, Bhatia R et al. Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2005; 11: 307–313.

    Article  CAS  PubMed  Google Scholar 

  47. Farag SS . Chronic graft-versus-host disease: where do we go from here? Bone Marrow Transplant 2004; 33: 569–577.

    Article  CAS  PubMed  Google Scholar 

  48. Vogelsang GB . How I treat chronic graft-versus-host disease. Blood 2001; 97: 1196–1201.

    Article  CAS  PubMed  Google Scholar 

  49. Akpek G, Lee SJ, Flowers ME, Pavletic SZ, Arora M, Lee S et al. Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study. Blood 2003; 102: 802–809.

    Article  CAS  PubMed  Google Scholar 

  50. Medsger TA, Steen VD, Ziegler G, Rodnan GP . The natural history of skin involvement in progressive systemic sclerosis. Arthritis Rheum 1980; 23: 720 (abstract).

    Google Scholar 

  51. Kahaleh MB, Sultany GL, Smith EA, Huffstutter JE, Loadholt CB, LeRoy EC et al. A modified scleroderma skin scoring method. Clin Exp Rheumatol 1986; 4: 367–369.

    CAS  PubMed  Google Scholar 

  52. Seaton ED, Szydlo RM, Kanfer E, Apperley JF, Russell-Jones R . Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response. Blood 2003; 102: 1217–1223.

    Article  CAS  PubMed  Google Scholar 

  53. Apisarnthanarax N, Donato M, Korbling M, Couriel D, Gajewski J, Giralt S et al. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results. Bone Marrow Transplant 2003; 31: 459–465.

    Article  CAS  PubMed  Google Scholar 

  54. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institute of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945–955.

    Article  PubMed  Google Scholar 

  55. Stewart BL, Storer B, Storek J, Deeg HJ, Storb R, Hansen JA et al. Duration of immunosuppressive treatment for chronic graft-versus-host disease. Blood 2004; 104: 3501–3506.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H T Greinix.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Greinix, H., Socié, G., Bacigalupo, A. et al. Assessing the potential role of photopheresis in hematopoietic stem cell transplant. Bone Marrow Transplant 38, 265–273 (2006). https://doi.org/10.1038/sj.bmt.1705440

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705440

Keywords

This article is cited by

Search

Quick links